We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Drugmakers Hit Wall in Quest for Generic Version of Allergan’s Glaucoma Drug Combigan
Drugmakers Hit Wall in Quest for Generic Version of Allergan’s Glaucoma Drug Combigan
August 23, 2011
A Texas federal judge has upheld four patents covering Allergan’s glaucoma drug Combigan, shutting out generic competition until 2022.